Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Rubrofusarin gentiobioside
Cat. No.:
OB0225LY-0208
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
Rubrofusarin gentiobioside is a compound that significantly reduces TGF-β1 and fibronectin expression and NF-κB DNA binding activity.
Synonym:
Rubrofusarin-6-O-beta-D-gentiobioside; 24577-90-0; Rubrofusarin-6-O-beta-gentiobioside; 5-Hydroxy-8-methoxy-2-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxybenzo[g]chromen-4-one
CAS No.:
24577-90-0
Compound CID:
503733
Formula:
C27H32O15
Formula Weight:
596.53
Specification
Relative Density:
1.69 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Rubrofusarin gentiobioside can be used in the study of diabetic complications associated with advanced glycosylation end-products.
Library Information
Targets:
MAPK family; Transcription factors ; TGF-beta/Smad
Receptors:
ERK; NF-κB; TGF-β receptor
Pathways:
NF-κB; Stem cells; MAPK
Plate Number:
AOCL-3
Plate Location:
f2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
22.5 mg/mL; 37.72 mM
